June 2025—Beckman Coulter Diagnostics announced that its DxC 500i clinical analyzer received FDA 510(k) clearance. The integrated chemistry and immunoassay analyzer has a throughput of up to 800 clinical chemistry tests and 100 immunoassay tests per hour and features FlexMode operations, which prioritize immunoassay and chemistry testing according to each sample’s urgency. The sample handler manages repeats and reruns without operator intervention and pulls in a new sample rack as soon as the previous rack is offloaded. The analyzer’s intuitive interface supports users through proactive task indicators with step-by-step instructions.
The DxC 500i has been available since July 2024 in countries that accept the CE mark.
Beckman Coulter Diagnostics, 714-993-5321